Business Wire

GLOBAL-RAYTUR

11.5.2018 04:02:08 CEST | Business Wire | Press release

Share
31st World Ports Conference Emblem Launched at Baku, Azerbaijan

On May 9th , the mid-term conference of the World Ports Conference was held by International Association of Ports and Harbors (IAPH) in Baku, Azerbaijan. Over 300 ports and port-related companies and organizations worldwide participated in the Conference. As the host for World Ports Conference 2019 and an important foreign trade port of China, Guangzhou Port Authority extended its warm invitation to all guests.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180510006415/en/

To host World Ports Conference 2019 is a milestone for Guangzhou Port. It is also an important step to accelerate the construction and development of national central cities and shipping hubs and the forming of a new pattern of all-around opening up in China. Ms.Yuan stated that “the development of the port cannot be separated from the city. It is even more than just cooperation with the port sector. Instead, the projects should be the trigger activating trades, logistics, ports and other departments to jointly develop and standardize the ports.” She also mentioned that during 31st World Ports Conference in Guangzhou next year the host will launch the ‘Friend Circle’ Initiative for ports along ‘Belt and Road’ to promote trade facilitation and internationalization of Chinese standards.

This time Guangzhou Port Authority chose “Collaborate Now, Create Future” as the theme in its exhibition area, where fully demonstrated the port of Guangzhou as an international shipping hub which is always dedicated to improving modern shipping logistics services and building a smart green and safe port, as well as deepening the exchanges and cooperation internationally. Guangzhou Port Authority also signed a sister port cooperation agreement with Baku International Sea Trade Port, who becomes the 42nd sister port of Guangzhou. Thanks to the conferences of IAPH, Guangzhou Port now maintains friendly cooperation with over 100 countries and 400 ports worldwide.

Since the issuance of the "Three-Year Action Plan for the Construction of the Guangzhou International Shipping Center" in 2015, three years of hard work has led to a big leap in port production, the gathering and radiation power has expanded, new breakthroughs have been made in factor gathering, and key projects such as the Nansha International Cruise Terminal have kicked off. The construction will add new momentum to the gateway hub. China (Guangzhou) International Freight single window has become a leading and demonstrative example among its peers in China.

With the launch of the new 3-year Action Plan, the port of Guangzhou will use the port as a fulcrum to strengthen the connectivity with the regions and cities along the “Belt and Road” initiative, and rapidly enhance the internationalization process of Guangzhou Port. By strictly following the “Belt and Road” initiative and grasping the opportunities of the policy of building a powerful country with strong traffic, powerful oceans, as well as the Bay Area construction of Guangdong, Hong Kong, and Macao, multiple measures will be taken together to promote the construction of the Guangzhou International Shipping Center and jointly create a world-class shipping hub.

Contact:

Global Raytur (Beijing) Public Communication Co.,Ltd
Shirley
86 13720002197
wangyishan@globalraytur.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye